Improving HPV vaccination rates through communication strategies
A Cluster Randomized Controlled Trial Testing Communication Strategies to Increase HPV Vaccination Intention: a Survey Experiment
This study is trying to find the best ways to communicate about the HPV vaccine to encourage more adults aged 18-45 to get vaccinated.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 3689 (estimated) |
| Ages | 18 Years to 45 Years |
| Sex | All |
| Sponsor | University of Pennsylvania Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Trial ID | NCT06784960 on ClinicalTrials.gov |
What this trial studies
This research aims to identify effective communication strategies to enhance the uptake of the HPV vaccine among adults aged 18-45. Utilizing an experimental design, the study will survey a national sample of over 3,689 adults to determine the most effective messages that can influence vaccine intentions. The multidisciplinary team involved brings expertise in communication, medicine, nursing, and behavior-change interventions, addressing a significant public health challenge of low HPV vaccination rates. The focus is on developing theory-based messages that can potentially increase vaccination rates in this demographic.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18-45 who have not received the HPV vaccine and are open to vaccination.
Not a fit: Patients who are under 18, over 45, or have already received the HPV vaccine will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly increase HPV vaccination rates, thereby reducing the incidence of HPV-related cancers.
How similar studies have performed: While there have been successful interventions to increase vaccine uptake in children, this approach focusing on adults is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18-45 years old Exclusion Criteria: * Under 18 and over 45 years old * Received HPV vaccine or unsure about receipt
Where this trial is running
Philadelphia, Pennsylvania
- University of Pennsylvania — Philadelphia, Pennsylvania, United States (Recruiting)
Study contacts
- Study coordinator: Florence Momplaisir
- Email: florence.momplaisir@pennmedicine.upenn.edu
- Phone: 215-746-8555
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.